Effect of Holly Mangrove Shower Gel in Atopic Dermatitis Patients
1 other identifier
interventional
30
1 country
1
Brief Summary
Atopic dermatitis is a chronic intermittent inflammatory skin disease. Currently, there are many cosmeceutical skin products in which their major action affects skin hydration and skin barrier function. In addition, there are some herbal medication remedies used for the treatment of skin diseases based on the knowledge of Thai traditional medicine. Patients with pruritic rash symptoms who attended the Center of Applied Thai Traditional Medicine, Siriraj Hospital, were prescribed the Holly Mangrove Shower Gel to use and on the follow-up appointment showed significant improvement. Nevertheless, the knowledge of using this herbal medication for treating pruritic skin rash so far has been categorized as folk wisdom and not been confirmed by any clinical-trial study on its efficacy and mechanism of action. Research teams chose Holly Mangrove Shower Gel containing Acanthus ebracteatus Vahl to act as adjunctive for treating atopic dermatitis. Thus, for the purpose of studying the efficacy of Holly Mangrove Shower Gel containing Acanthus ebracteatus Vahl in improving the skin barrier function in atopic dermatitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_3
Started Jul 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 26, 2014
CompletedFirst Posted
Study publicly available on registry
June 30, 2014
CompletedStudy Start
First participant enrolled
July 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2016
CompletedMarch 16, 2016
March 1, 2016
1.6 years
June 26, 2014
March 15, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Improvement of skin barrier function
•Measurement of bioengineering property of skin using Tewameter (transepidermal water loss), Corneometer (stratum corneum hydration), pH meter (skin pH), sebumeter (sebum), and visioscan (wrinkle)
baseline, 2 week
Secondary Outcomes (1)
Reduction of severity of pruritus
baseline, 2 week
Study Arms (2)
Placebo shower gel
PLACEBO COMPARATOR•Wash forearm by prepared placebo shower gel twice a day
Holly Mangrove Shower Gel
ACTIVE COMPARATOR•Wash forearm by Holly Mangrove Showver gel twice a day
Interventions
Wash forearm with placebo shower gel for 10 seconds, twice a day, 2 weeks
Wash forearm with Holly Mangrove shower gel containing Acanthus ebracteatus Vahl for 10 seconds, twice a day, 2 weeks
Eligibility Criteria
You may qualify if:
- Age 18 years old or above
- Diagnosed as atopic dermatitis (Hanafin and Rajka criteria)
- No active dermatitis within 2 weeks
You may not qualify if:
- Pregnancy or lactation
- Any other skin diseases on forearms
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Siriraj Hospital Mahidol Univeristy
Bangkok, Bangkok, 10700, Thailand
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Papapit Tuchinda, MD
Mahidol University
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 26, 2014
First Posted
June 30, 2014
Study Start
July 1, 2014
Primary Completion
February 1, 2016
Study Completion
February 1, 2016
Last Updated
March 16, 2016
Record last verified: 2016-03